BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 5, 2000
View Archived Issues
Array BioPharma and Lilly form drug discovery collaboration
Read More
CollaGenex seeks FDA approval for new dosage form of Periostat
Read More
Karo Bio to acquire Novalon
Read More
Significant progress reported by Genzyme Molecular Oncology for 1999
Read More
Aventis launches Arava in Canada for treatment of rheumatoid arthritis
Read More
First phase II clinical trial of ABX-IL-8 begins in psoriasis
Read More
New phosphoglycolipid useful for protecting against cardiac ischemia-reperfusion damage
Read More
Chemokine receptor modulators in early development at AstraZeneca
Read More
Helsinn initiates phase III testing of in-licensed antiemetic
Read More
Carboxylic acid PPAR modulators presented by Ono
Read More
Merck's new GABA-A receptor modulators particularly useful for Alzheimer's disease
Read More
Scios compounds useful for conditions characterized by excess p38alpha or TGF-beta activity
Read More
Merck describes preparation and use of new anticoagulants
Read More
Uprima to be considered for ED next week by FDA advisory committee
Read More
Another indication for Enbrel will be discussed at advisory committee meeting
Read More
Novel tubulin-binding antimitotic agent characterized in vitro by Abbott scientists
Read More
Celgene's IMiDs and thalidomide show activity as COX-2 inhibitors
Read More
WP-769: a doxorubicin analogue that combines oral activity and enhanced effect against topo II
Read More
Promising flavonoid discovered by Dutch investigators for preventing doxorubicin cardiotoxicity
Read More
Ro-31-7453: extensive preclinical and early clinical data presented this week to the AACR
Read More
DuPont licenses two cardiac compounds from Adenosine Therapeutics
Read More
Clinical study suggests SuperGen's Nipent effective in treating GVHD
Read More
FDA gives go-ahead for Access to commence OraDisc clinical trials
Read More
Matrix files initial section of IntraDose NDA with FDA
Read More
German researchers provide data supporting therapy with S-4718 + ciclosporin in cardiac transplants
Read More
Efficacy and mechanism of action of FR-167653 in protecting against lung I/R injury
Read More
Newly formed company to market TOBI in the Dutch market
Read More